Pfizer Inc (PFE)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	2,119,000	10,482,000	21,472,000	29,051,000	31,372,000	29,771,000	29,309,000	24,966,000	21,979,000	19,432,000	12,755,000	10,681,000	9,159,000	7,730,000	13,941,000	15,498,000	16,027,000	16,217,000	12,651,000	11,477,000
Revenue (ttm)	US$ in thousands	58,497,000	68,538,000	77,944,000	92,952,000	100,331,000	100,771,000	101,921,000	92,738,000	81,285,000	63,407,000	51,332,000	44,201,000	41,650,000	47,096,000	47,667,000	49,131,000	50,098,000	51,534,000	52,176,000	52,443,000
Net profit margin		3.62%	15.29%	27.55%	31.25%	31.27%	29.54%	28.76%	26.92%	27.04%	30.65%	24.85%	24.16%	21.99%	16.41%	29.25%	31.54%	31.99%	31.47%	24.25%	21.88%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $2,119,000K ÷ $58,497,000K
= 3.62%

The net profit margin of Pfizer Inc. fluctuated over the past eight quarters, ranging from 3.62% in Q4 2023 to 31.27% in Q4 2022. The trend indicates a significant decline in profitability from Q4 2022 to Q4 2023. The Q1 2023 net profit margin of 31.26% saw a slight recovery compared to the previous quarter but remained lower than the levels observed in Q2 and Q3 of 2022. The net profit margin peaked in Q2 2023 at 27.55% but gradually declined in the following quarters. Overall, Pfizer's net profit margin has shown variability in recent quarters, with Q4 2023 recording the lowest profitability among the reported periods. This trend suggests a need for further analysis to understand the factors contributing to the fluctuations in Pfizer's profitability.